CD274 and neoplasm: Programmed death-ligand 1 (PD-L1) Tumor Proportion Score was 0. Biomarker findings revealed a microsatellite status of MS-Stable and a tumor mutational burden (TMB) of 8 Muts, both of these with no associated therapies or clinical trials. There were no other reportable alterations with diagnostic claims on next-generation sequencing.